Progenra Inc. sees significant market opportunities in developing products to treat cancer, muscle wasting, inflammation, and metabolic, infectious and neurodegenerative diseases. We use an exclusive research platform to identify novel therapeutic medicines based on the ubiquitin and ubiquitin-like protein pathways. We seek to add value to existing pharmaceutical and biotechnology company programs or create new programs. Progenra invites funding and investment opportunities from small and large institutions.
Please contact Progenra Business Development offices for further discussion.